Literature DB >> 2199735

Laboratory models of sepsis and septic shock.

M P Fink1, S O Heard.   

Abstract

That there are so many models of sepsis and septic shock is tacit evidence that none of them are perfect. Although sepsis presents in many forms clinically, most clinicians would probably agree that virtually all severely septic patients manifest respiratory failure and ventilator dependence. Furthermore, failure of organs other than the lungs typically occurs days to weeks after the onset of the septic process. Although early deaths occur commonly in some situations (e.g., meningococcemia, pneumococcal bacteremia in asplenic individuals, Gram-negative bacteremia in the setting of profound granulocytopenia), most deaths due to sepsis occur after a protracted course in an intensive care unit. Thus, for certain important experiments, there is a need for an animal model of severe chronic sepsis characterized by these features: persistent hypermetabolism, low systemic vascular resistance, respiratory failure severe enough to require mechanical ventilation, late (nonpulmonary) organ system failure, and death. Obviously, creation of such a model will require a major commitment of resources, because it will require, in essence, the creation of an animal intensive care unit. Nevertheless, we believe that progress in sepsis-related research would be substantially facilitated were such a model available. Even without such a model, progress will continue in this field. A wide variety of good animal models are already available to investigators. In the next decade, as new methods, such as the powerful tools of molecular biology, are applied to problems related to the sepsis syndrome, these models will be invaluable in improving our understanding of pathophysiology and in developing new and more effective approaches toward therapy.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2199735     DOI: 10.1016/0022-4804(90)90260-9

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  104 in total

1.  In vivo measurement of nitric oxide production in porcine gut, liver and muscle during hyperdynamic endotoxaemia.

Authors:  Maaike J Bruins; Wouter H Lamers; Alfred J Meijer; Peter B Soeters; Nicolaas E P Deutz
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

2.  Shock-induced neutrophil mediated priming for acute lung injury in mice: divergent effects of TLR-4 and TLR-4/FasL deficiency.

Authors:  Alfred Ayala; Chun-Shiang Chung; Joanne L Lomas; Grace Y Song; Lesley A Doughty; Stephen H Gregory; William G Cioffi; Brian W LeBlanc; Jonathan Reichner; H Hank Simms; Patricia S Grutkoski
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

3.  HMR1402, a potassium ATP channel blocker during hyperdynamic porcine endotoxemia: effects on hepato-splanchnic oxygen exchange and metabolism.

Authors:  Pierre Asfar; Zsolt Iványi; Hendrik Bracht; Balázs Hauser; Antje Pittner; Damian Vassilev; Marek Nalos; Xavier Maurice Leverve; Uwe Bernd Brückner; Peter Radermacher; Gebhard Fröba
Journal:  Intensive Care Med       Date:  2004-03-26       Impact factor: 17.440

Review 4.  Differential Paradigms in Animal Models of Sepsis.

Authors:  S Manoj Kumar Kingsley; B Vishnu Bhat
Journal:  Curr Infect Dis Rep       Date:  2016-09       Impact factor: 3.725

5.  Involvement of Gr-1 dull+ cells in the production of TNF-α and IL-17 and exacerbated systemic inflammatory response caused by lipopolysaccharide.

Authors:  Daiki Tanno; Yukiko Akahori; Masahiko Toyama; Ko Sato; Daisuke Kudo; Yuzuru Abe; Tomomitsu Miyasaka; Hideki Yamamoto; Keiko Ishii; Emi Kanno; Ryoko Maruyama; Shigeki Kushimoto; Yoichiro Iwakura; Kazuyoshi Kawakami
Journal:  Inflammation       Date:  2014-02       Impact factor: 4.092

6.  Does pharmacological dose of parenteral arginine have beneficial effect in rats with sub-acute peritonitis?

Authors:  Hui-Chen Lo; Shih-Chi Wu; Yao-Horng Wang; Chien-Hsing Lee
Journal:  Pediatr Surg Int       Date:  2010-02-24       Impact factor: 1.827

Review 7.  Modeling sepsis in the laboratory: merging sound science with animal well-being.

Authors:  Jean A Nemzek; Kelly M S Hugunin; Mark R Opp
Journal:  Comp Med       Date:  2008-04       Impact factor: 0.982

Review 8.  Scientific and clinical challenges in sepsis.

Authors:  Luis Ulloa; Michael Brunner; Laura Ramos; Edwin A Deitch
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

9.  Microvascular perfusion is impaired in a rat model of normotensive sepsis.

Authors:  C Lam; K Tyml; C Martin; W Sibbald
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

10.  Chronic Escherichia coli infection induces muscle wasting without changing acetylcholine receptor numbers.

Authors:  Christiane G Frick; Heidrun Fink; Maria L Gordan; Barbara Eckel; J A Jeevendra Martyn; Manfred Blobner
Journal:  Intensive Care Med       Date:  2007-10-20       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.